Acacia Research Corp.

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: US0038813079
USD
3.83
-0.03 (-0.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Acacia Research Corp. stock-summary
stock-summary
Acacia Research Corp.
Miscellaneous
Acacia Research Corporation, through its subsidiaries, invests in, licenses and enforces patented technologies. The Company's operating subsidiaries partner with inventors and patent owners, applying their legal and technology expertise to patent assets to unlock the financial value in their patented inventions. The Company's operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, where necessary, with the enforcement against unauthorized users of their patented technologies through the filing of patent infringement litigation. The Company's operating subsidiaries own or control the rights to multiple patent portfolios, which include the United States patents and certain foreign counterparts, covering technologies used in a range of industries.
Company Coordinates stock-summary
Company Details
4 Park Plaza, Suite 550 , IRVINE CA : 92614
stock-summary
Tel: 1 949 48083001 646 8094048
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 39 Schemes (10.46%)

Foreign Institutions

Held by 24 Foreign Institutions (0.96%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Ms. Maureen O'Connell
Independent Chairman of the Board
Mr. Alfred Tobia
President, Chief Investment Officer, Director
Mr. Clifford Press
Chief Executive Officer, Director
Mr. Isaac Kohlberg
Independent Director
Mr. Jonathan Sagal
Independent Director
Ms. Katharine Wolanyk
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
51 Million
(Quarterly Results - Jun 2025)
Net Profit:
-1 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 342 Million (Micro Cap)

stock-summary
P/E

63.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.44

stock-summary
Return on Equity

-0.01%

stock-summary
Price to Book

0.63